Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EVAX Evaxion Biotech A/S

Trading 06-26 15:47:58 EDT

2.75

-0.06

-2.14%

High3.00	Low2.72	Vol39.20K
Open3.00	D1 Closing2.81	Amplitude9.82%
Mkt Cap14.88M	Tradable Cap9.47M	Total Shares5.41M
T/O109.51K	T/O Rate1.14%	Tradable Shares3.44M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"EVAX","market":"US","secType":"STK","nameCN":"Evaxion Biotech A/S","latestPrice":2.75,"timestamp":1719431014620,"preClose":2.81,"halted":0,"volume":39203,"delay":0,"floatShares":3442101,"shares":5411054,"eps":-4.513135,"marketStatus":"Trading","change":-0.06,"latestTime":"06-26 15:47:58 EDT","open":3,"high":3,"low":2.724,"amount":109505.44587750001,"amplitude":0.098221,"askPrice":2.86,"askSize":200,"bidPrice":2.76,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.513135,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1719432000000},"marketStatusCode":2,"adr":0,"adrRate":10,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":2.81,"preHourTrading":{"tag":"盘前","latestPrice":2.93,"preClose":2.81,"latestTime":"09:25 EDT","volume":12638,"amount":37131.9201184,"timestamp":1719408307437},"postHourTrading":{"tag":"盘后","latestPrice":2.81,"preClose":2.81,"latestTime":"19:51 EDT","volume":51,"amount":146.22,"timestamp":1719359481206},"volumeRatio":1.380114,"impliedVol":2.1042,"impliedVolPercentile":0.047},"requestUrl":"/m/hq/s/EVAX/wiki","defaultTab":"wiki","newsList":[{"id":"2446939349","title":"Evaxion Biotech’s Innovative Cancer Vaccine Patent Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2446939349","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446939349?lang=en_us&edition=fundamental","pubTime":"2024-06-26 20:57","pubTimestamp":1719406667,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX) has released an update. Evaxion Biotech has received positive feedback on its patent application for a new AI-based method t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotechs-innovative-cancer-vaccine-patent-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotechs-innovative-cancer-vaccine-patent-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","BK4139","LU2065732104.USD","EVAX","BK4097"],"gpt_icon":0},{"id":"2446361154","title":"BRIEF-Evaxion Receives Positive Feedback On Patent Application For AI-Based Novel Cancer Vaccine Target Identification Method","url":"https://stock-news.laohu8.com/highlight/detail?id=2446361154","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446361154?lang=en_us&edition=fundamental","pubTime":"2024-06-26 19:34","pubTimestamp":1719401673,"startTime":"0","endTime":"0","summary":"June 26 (Reuters) - Evaxion Biotech A/S   :   * EVAXION RECEIVES POSITIVE FEEDBACK ON PATENT APPLICATION FOR AI-BASED NOVEL CANCER VACCINE TARGET IDENTIFICATION METHODSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2446136166","title":"Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification Method","url":"https://stock-news.laohu8.com/highlight/detail?id=2446136166","media":"GlobeNewswire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446136166?lang=en_us&edition=fundamental","pubTime":"2024-06-26 19:30","pubTimestamp":1719401400,"startTime":"0","endTime":"0","summary":"Positive Feedback Received: An International Preliminary Report on Patentability (IPRP) indicates promising prospects for obtaining granted patents and protecting the inventionUnique Attributes and In","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/06/26/2904419/0/en/Evaxion-Receives-Positive-Feedback-on-Patent-Application-for-AI-Based-Novel-Cancer-Vaccine-Target-Identification-Method.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2446083849","title":"Evaxion Biotech Updates Warrant Exercise Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2446083849","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446083849?lang=en_us&edition=fundamental","pubTime":"2024-06-25 06:55","pubTimestamp":1719269706,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX) has released an update. Evaxion Biotech A/S has announced an amendment to the terms of warrants issued in December 2023, adj...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-updates-warrant-exercise-price?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-updates-warrant-exercise-price?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2445006800","title":"European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2445006800","media":"MT Newswires Live","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2445006800?lang=en_us&edition=fundamental","pubTime":"2024-06-24 23:31","pubTimestamp":1719243099,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher Monday, rising 0.84% to 1,428.35 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company argenx  and financial services company Banco Bilbao Vizcaya Argentaria , which increased 9.3% and 3.3% respectively. They were followed by biopharmaceutical company Grifols  and pharmaceutical company Sanofi , which were up 2.8% and 3% respectively.The decliners from continental Europe were led by biotech firm Evaxion Biotech  and medical device maker EDAP TMS , which fell 5.7% and 1.3% respectively. They were followed by furniture maker Natuzzi  and telecommunications company VEON , which dropped 0.2% and 1.3% respectively.From the UK and Ireland, the gainers were led by insurance firm Prudential  and biopharmaceutical company Amarin , which increased 7.9% and 7.4% respectively. They were followed by biopharmaceutical company Verona Pharma plc  and tobacco c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","BK4132","BK4107","EVAX","LU0889565916.HKD","BK4117","AKTX","BBVA","BK7062","BK4585","NTZ","BK4207","SNY","BK4588","VRNA","GRFS","BK4082","BK4162","PUK","TRIB","BK4139","ARGX","BDRX","LU0109394709.USD","BK4007","VEON","BK4095","MREO","EDAP","AMRN","AFG","BTI.AU","BTI","BK4505","BK4075"],"gpt_icon":1},{"id":"2444328864","title":"European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2444328864","media":"MT Newswires Live","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2444328864?lang=en_us&edition=fundamental","pubTime":"2024-06-18 23:18","pubTimestamp":1718723905,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were moving slightly higher late Tuesday morning, rising 0.14% to 1,418.16 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion Biotech  was up 11% and biopharmaceutical company Genfit  added 3.4%. They were followed by oil and gas companies TotalEnergies  and Eni , which were both up 1.6%.The decliners from continental Europe were led by semiconductor company Sequans Communications  and telecommunications company VEON , which lost 9.4% and 3%, respectively. Biopharmaceutical company Cellectis  retreated 1.9% and medical device maker EDAP TMS  lost 1.5%.From the UK and Ireland, the gainers were led by cruise line operator Carnival  and utilities company National Grid , which increased 2% and 1.5%, respectively. They were followed by oil and gas company BP  and biopharmaceutical company Akari Therapeutics , which rose 1.1% and 1%, respectively.The decliners from the UK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GNFT","BK4132","BK4107","LU1162221912.USD","SQNS","EVAX","BK4117","AKTX","CLLS","BK4585","BK4532","BK4561","CUK","E","LU1829250122.USD","BK4201","LU2237443382.USD","BK4588","VRNA","LU2237443622.USD","ADAP","TTE","BK4082","BK4141","BK4139","BP","NGG","LU2237443549.SGD","BK4007","LU2237443978.SGD","VEON","BK4208","BK4142","MREO","EDAP","AFG","LU0320765646.SGD","AUTL","BK4505"],"gpt_icon":0},{"id":"2444619629","title":"Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2444619629","media":"MT Newswires Live","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2444619629?lang=en_us&edition=fundamental","pubTime":"2024-06-17 23:14","pubTimestamp":1718637268,"startTime":"0","endTime":"0","summary":"Bank stocks were helping European equities traded in the US as American depositary receipts nudge marginally higher late Monday morning, rising 0.047% to 1,409.42 on the S&P Europe Select ADR Index. F","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2092937221.SGD","BK4207","ING.AU","MREO","LU1506573853.SGD","BK4139","TRIB","BK4505","BK4551","GB00BDT5M118.USD","LU0889565916.HKD","VRNA","LU1019634622.SGD","CRH","BK4082","LU2041044095.USD","SLN","BK4007","AKTX","EVAX","SAN.AU","DBVT","SNY","LU0320765992.SGD","LU1019632923.USD","CLLS","BK4548","LYG","NCNA","BK7142","LU1093756325.SGD","BK4568","BK4117","LU2463526074.USD","BK4585","LU0109394709.USD","LU0238689110.USD","ASND","ING","LU1039938227.USD","BK4107","BK4011","BNTX","LU1093756168.USD","LU1291149836.SGD","BK7141","SAN","BK4521","AFG","BK7505"],"gpt_icon":0},{"id":"2444993191","title":"Evaxion’s AI-Crafted Vaccine Shows Promise in Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2444993191","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2444993191?lang=en_us&edition=fundamental","pubTime":"2024-06-17 23:13","pubTimestamp":1718637223,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX) has released an update. Evaxion Biotech’s AI-designed personalized cancer vaccine, EVX-01, has shown a 67% objective respons...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxions-ai-crafted-vaccine-shows-promise-in-melanoma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxions-ai-crafted-vaccine-shows-promise-in-melanoma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2444164855","title":"BRIEF-Evaxion Publishes Data Showing 67% Objective Response Rate In Metastatic Melanoma For AI-Designed Personalized Cancer Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2444164855","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2444164855?lang=en_us&edition=fundamental","pubTime":"2024-06-17 20:48","pubTimestamp":1718628531,"startTime":"0","endTime":"0","summary":"June 17  - Evaxion Biotech A/S   :   * EVAXION PUBLISHES DATA, SHOWING 67% OBJECTIVE RESPONSE RATE IN METASTATIC MELANOMA FOR THE AI-DESIGNED PERSONALIZED CANCER VACCINE EVX-01, IN LEADING MEDICAL JOURNAL   * EVAXION BIOTECH A/S: ONE-YEAR CLINICAL EFFICACY READOUT FROM PHASE 2 STUDY IS ON TRACK FOR Q3 2024Source text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX"],"gpt_icon":0},{"id":"2444610831","title":"Evaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal","url":"https://stock-news.laohu8.com/highlight/detail?id=2444610831","media":"GlobeNewswire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2444610831?lang=en_us&edition=fundamental","pubTime":"2024-06-17 20:44","pubTimestamp":1718628240,"startTime":"0","endTime":"0","summary":"A 67% objective response rate (ORR) is reported in the publication summarizing results from the Phase 1 study assessing Evaxion’s personalized cancer vaccine, EVX-01, in patients with metastatic melan","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/06/17/2899676/0/en/Evaxion-Publishes-Data-Showing-67-Objective-Response-Rate-in-Metastatic-Melanoma-for-the-AI-Designed-Personalized-Cancer-Vaccine-EVX-01-in-Leading-Medical-Journal.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVX","EVAX"],"gpt_icon":0},{"id":"2442531800","title":"European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2442531800","media":"MT Newswires Live","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2442531800?lang=en_us&edition=fundamental","pubTime":"2024-06-11 23:11","pubTimestamp":1718118680,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending sharply lower late Tuesday morning, falling 1.34% to 1,420.05 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company VEON  and pharmaceutical company Ascendis Pharma , which rose 1.4% and 1.1% respectively. They were followed by semiconductor company Sequans Communications  and biotech firm BioNTech , which were up 0.8% and 0.2% respectively.The decliners from continental Europe were led by biotech firm Evaxion Biotech  and biopharmaceutical company Genfit , which fell 6.3% and 5.4% respectively. They were followed by biopharmaceutical company Cellectis  and financial services company Banco Santander , which dropped 2.8% and 2.5% respectively.From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech  and biopharmaceutical company Amarin , which surged 13.5% and 13.3% respectively. They were followed by biopharmaceutical company Aka","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BNTX","LU0889565916.HKD","AUTL","CLLS","AKTX","BK4568","BK4585","EVAX","BK4521","BK4139","ASND","GNFT","LU0320765992.SGD","BHP","BK4141","BHP.AU","BK7142","SQNS","AMRN","BK4548","BDRX","BK7095","BK4117","SAN","VRNA","BK7507","BK4551","BK4007","BK4207","TRIB","BK7511","BK4132","NCNA","BK4535","BK4107","AFG","BK4168","SAN.AU","VEON","LU0109394709.USD","BK4082"],"gpt_icon":1},{"id":"2441131014","title":"Evaxion Biotech Drives Innovation with Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2441131014","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2441131014?lang=en_us&edition=fundamental","pubTime":"2024-06-08 05:57","pubTimestamp":1717797470,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX) has released an update. Evaxion Biotech A/S, operating also under the name NovVac A/S, aims to develop advanced software for...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-drives-innovation-with-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-drives-innovation-with-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2440023440","title":"European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2440023440","media":"MT Newswires Live","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2440023440?lang=en_us&edition=fundamental","pubTime":"2024-06-04 23:10","pubTimestamp":1717513829,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.61% to 1,415.12 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion Biotech  and telecommunications operator Telefonica , which rose 2% and 1.8%, respectively. They were followed by biopharmaceutical company Calliditas Therapeutics  and internet advertising firm Criteo , which were up 0.8% each.The decliners from continental Europe were led by petroleum refiner Equinor  and financial services company Banco Bilbao Vizcaya Argentaria , which fell 4.8% and 3.4%, respectively. They were followed by biopharmaceutical companies Cellectis  and MorphoSys , which were down 3.1% and 2.8%, respectively.From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech  and cruise line operator Carnival , which increased 6.8% and 5.6%, respectively. They were followed by biopharmaceutical company Akari Therapeutics ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TEF","BK4007","BK4168","BK4208","ADAP","EVAX","BDRX","BK4588","CRTO","CALT","BK4532","CLLS","BK7511","CUK","BK4009","AKTX","BK4142","BHP","BK4585","BK7095","EQNR","BK4115","AFG","AMRN","NGG","BK4117","BK4107","TRIB","BK7507","BK4139","BK4207","MOR","BK4082","BBVA","BK4201","BHP.AU"],"gpt_icon":1},{"id":"2440328860","title":"Evaxion Biotech: Promising Phase 2 Data and PIONEER AI Model Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2440328860","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2440328860?lang=en_us&edition=fundamental","pubTime":"2024-06-04 18:17","pubTimestamp":1717496228,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Swayampakula Ramakan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evaxion-biotech-promising-phase-2-data-and-pioneer-ai-model-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evaxion-biotech-promising-phase-2-data-and-pioneer-ai-model-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2440494508","title":"European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2440494508","media":"MT Newswires Live","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2440494508?lang=en_us&edition=fundamental","pubTime":"2024-06-03 23:03","pubTimestamp":1717427007,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts fell in Monday trading, declining 0.53% to 1,420.98 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies  and Genfit , which rose 6.9% and 6.8% respectively. They were followed by biopharmaceutical company Grifols  and biotech firm BioNTech , which were up 3.4% and 2.8% respectively.The decliners from continental Europe were led by medical device maker EDAP TMS  and semiconductor company Sequans Communications , which dropped 6.6% and 5.2% respectively. They were followed by biotech firm Evaxion Biotech  and oil and gas company TotalEnergies , which fell 2.7% and 1.9% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals  and Bicycle Therapeutics , which climbed 8.9% and 6% respectively. They were followed by biotech firm Trinity Biotech  and biopharmaceutical company Verona Pharma , wh","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","DBVT","LU1093756168.USD","CRH","BCYC","BK4011","GB00BDT5M118.USD","GSK.UK","LU2041044095.USD","LU1829250122.USD","ADAP","BNTX","EVAX","BDRX","LU1019634622.SGD","BK4588","TTE","LU2237443382.USD","LU1506573853.SGD","EDAP","LU2463526074.USD","LU1039938227.USD","BK4532","BK4141","AKTX","BK4585","GSK","BK4535","BK4551","LU2237443622.USD","VRNA","AFG","BK4568","LU1019632923.USD","LU1093756325.SGD","BK4117","BK4107","BK4548","TRIB","LU2237443978.SGD","GNFT","BK4139","LU2237443549.SGD","GRFS","LU2092937221.SGD","BK4082","SQNS","BK4201","LU1291149836.SGD","BK4561"],"gpt_icon":0},{"id":"2440496641","title":"Evaxion Biotech Announces Warrant Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2440496641","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2440496641?lang=en_us&edition=fundamental","pubTime":"2024-06-03 21:51","pubTimestamp":1717422685,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX) has released an update. Evaxion Biotech A/S, a company focused on developing advanced software for new immune therapies and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-announces-warrant-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-announces-warrant-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2440460790","title":"Evaxion Biotech’s Vaccine Shows Promise in Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2440460790","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2440460790?lang=en_us&edition=fundamental","pubTime":"2024-06-03 20:50","pubTimestamp":1717419019,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX) has released an update. Evaxion Biotech reported promising results from a Phase 2 clinical trial of their AI-designed cancer...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotechs-vaccine-shows-promise-in-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotechs-vaccine-shows-promise-in-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVAX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evaxionbiotech.com","stockEarnings":[{"period":"1week","weight":0.0524},{"period":"1month","weight":-0.3045},{"period":"3month","weight":-0.0633},{"period":"6month","weight":-0.5987},{"period":"1year","weight":-0.7678},{"period":"ytd","weight":-0.5902}],"compareEarnings":[{"period":"1week","weight":-0.0067},{"period":"1month","weight":0.0291},{"period":"3month","weight":0.0414},{"period":"6month","weight":0.1429},{"period":"1year","weight":0.2628},{"period":"ytd","weight":0.1463}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.269805},{"month":2,"riseRate":0,"avgChangeRate":-0.053098},{"month":3,"riseRate":0,"avgChangeRate":-0.133841},{"month":4,"riseRate":0.75,"avgChangeRate":0.137684},{"month":5,"riseRate":0.25,"avgChangeRate":-0.067063},{"month":6,"riseRate":0.25,"avgChangeRate":-0.061133},{"month":7,"riseRate":0.333333,"avgChangeRate":0.07933},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.117777},{"month":9,"riseRate":1,"avgChangeRate":0.199635},{"month":10,"riseRate":0.333333,"avgChangeRate":0.04085},{"month":11,"riseRate":0,"avgChangeRate":-0.278598},{"month":12,"riseRate":0,"avgChangeRate":-0.126361}],"exchange":"NASDAQ","name":"Evaxion Biotech A/S","nameEN":"Evaxion Biotech A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evaxion Biotech A/S,EVAX,Evaxion Biotech A/S股票,Evaxion Biotech A/S股票老虎,Evaxion Biotech A/S股票老虎国际,Evaxion Biotech A/S行情,Evaxion Biotech A/S股票行情,Evaxion Biotech A/S股价,Evaxion Biotech A/S股市,Evaxion Biotech A/S股票价格,Evaxion Biotech A/S股票交易,Evaxion Biotech A/S股票购买,Evaxion Biotech A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}